Can you get medical cannabis for ADHD in the UK?

ADHD is one of the fastest-growing reasons people approach private clinics, and one of the weakest areas of evidence in the whole field. Both of those things are worth knowing before you spend money on a consultation.

Is ADHD treated with medical cannabis in the UK?

It is assessed privately, and the number of people asking about it has risen sharply. It is not an NHS treatment, no cannabis-based product is licensed for ADHD, and NICE guidance on ADHD does not include cannabis-based medicines among the treatments it recommends.

The rise in enquiries has a straightforward explanation that has nothing to do with the evidence: NHS adult ADHD assessment waiting lists in parts of the UK run to several years, and the licensed stimulant medicines have been subject to repeated supply shortages. People who cannot get assessed, or cannot get their usual medicine, look for alternatives.

That is an understandable reason to ask the question. It is not, on its own, a clinical reason for a specialist to answer yes.

What the evidence actually shows

There is one randomised controlled trial. It did not meet its primary endpoint. Everything else is observational, and observational data cannot separate a real effect from the relief of being treated at all.

The trial randomised thirty adults with ADHD to a cannabinoid oromucosal spray or placebo over six weeks. The primary outcome — a cognitive performance measure — did not reach statistical significance. Some secondary symptom measures showed improvement, which the authors themselves described as a signal worth testing properly rather than a result to act on.

A large systematic review of cannabinoids across mental health conditions reached the same conclusion for ADHD as it did for most psychiatric indications: there is not enough controlled evidence to support routine use. UK registry data reports symptom improvements in people prescribed for ADHD, with the usual caveat that people who stay in treatment and complete questionnaires are not a random sample of everyone who started.

What a specialist will want to see

There is no UK list of qualifying conditions, so nothing here entitles you to a prescription. For ADHD specifically, the diagnosis itself is usually the first thing examined, because a large proportion of enquiries come from people who have not yet been formally assessed.

• Whether ADHD has been formally diagnosed, by whom, and using what assessment
• Which licensed ADHD medicines you have tried, at what doses, and why each was stopped
• Whether a stimulant was ineffective, not tolerated, or simply unavailable
• Coexisting anxiety, depression, autism or substance use, which are common in ADHD
• Your personal and family history of psychosis, and your current mental health
• Whether you drive, operate machinery, or work in a safety-critical role

A specialist who offers to prescribe for ADHD without a diagnosis, or without your records, is not assessing you. That is one of the clearer warning signs described in Can I get medical cannabis for myself in the UK?

The general requirements — age, a documented diagnosis, the convention that two standard treatments have been tried, and access to your medical records — are covered in What are the requirements?

Risks and reasons a specialist may say no

This is the condition where the risk profile most directly contradicts the reason people ask. THC impairs sustained attention, working memory and reaction time in the short term — the exact functions ADHD already disrupts.

ADHD also carries an elevated baseline risk of substance use problems, which makes a careful specialist more cautious rather than less. Where ADHD coexists with a personal or family history of psychosis, that will normally count decisively against treatment.

The ordinary cautions apply too: drowsiness, dizziness, dry mouth, and driving impairment. Driving is covered in Can you drive on a medical cannabis prescription?

How medical cannabis is thought to help

Because the controlled evidence in ADHD is so limited, any account of a mechanism is speculative, and here it has to contend with a direct contradiction: the compound people most associate with cannabis impairs the very functions ADHD already disrupts.

The body has its own endocannabinoid system — a network of receptors and signalling molecules involved in regulating attention, mood, the stress response and sleep. THC and CBD interact with it in different ways: THC acts directly on cannabinoid receptors and is responsible for the intoxicating effects, and in the short term it impairs sustained attention, working memory and reaction time; CBD works more indirectly and is not intoxicating. If you want the underlying biology rather than the condition-specific picture, the guides on the endocannabinoid system and THC and CBD set it out in plain terms.

Some people report that it settles restlessness or helps them wind down, which is not the same as improving core ADHD symptoms, and the controlled evidence does not show a benefit to attention.

What treatment involves in practice

In the uncommon situation where a specialist does consider a monitored trial — normally only after a formal diagnosis and after licensed ADHD medicines have been tried — treatment follows the cautious pattern used across this field: start low, increase slowly, and review often.

Unlicensed cannabis-based products are prescribed on a named-patient basis, which places responsibility for the decision and for informed consent with the specialist rather than with a manufacturer's licence. Treatment usually begins at a low dose and is titrated upwards gradually, so that any benefit and any side effects can be judged against small, deliberate changes. Most prescriptions take the form of an oil or capsule taken by mouth, or dried flower for vaporising; the two behave differently in how quickly they act and how long they last, which is covered in how cannabis-based medicines are taken and how long they take to work.

Follow-up reviews are where the specialist checks whether the treatment is genuinely helping, whether attention or daytime function is being impaired rather than improved, and whether the dose needs adjusting — or whether it should be stopped. How a dose is set and changed is explained in how a dose is decided and adjusted, the range of unwanted effects in side effects of cannabis-based medicines, and the practical side of driving and work in the guides on driving and drug testing and work.

Questions worth asking your specialist

A good assessment is a two-way conversation. Whether or not treatment is offered, these are sensible questions to bring:

• Do I have a formal ADHD diagnosis, and is that a precondition here?
• Given that THC can impair attention, is a monitored trial reasonable at all?
• Have licensed ADHD medicines been properly tried, and were they ineffective, not tolerated, or just unavailable?
• How would we tell benefit apart from simply feeling calmer or more relaxed?
• What would tell us it is not working, and when would we stop?

If a clinic is reluctant to answer these plainly, that tells you something in itself. The broader question of whether treatment fits your situation is covered in can medical cannabis treat my condition?

If you want to take this further

The useful next step is a proper assessment, not a longer reading list. Gather your diagnosis, the treatments you have already tried and what happened with each, and a current list of your medicines — that is what a specialist needs in order to give you a straight answer.

The consultation itself, and what happens after it, is set out in What is the process to get a medical cannabis prescription? If ADHD is not the only thing you are being treated for, say so early: other conditions and other medicines change the assessment.

Patient guide · Written by the Flora House editorial team · Last reviewed: 7 October 2026